Carmil Azran
Rabin Medical Center
15 Papers
55 Citations
Carmil Azran is an academic researcher from Rabin Medical Center. The author has contributed to research in topics: Medicine & Sleeve gastrectomy. The author has an hindex of 7, co-authored 15 publications.
Chat about Author
Papers
Sleeve Gastrectomy Failure—Revision to Laparoscopic One-Anastomosis Gastric Bypass or Roux-n-Y Gastric Bypass: a Multicenter Study
Shlomi Rayman,Dan Assaf,Carmil Azran,Gideon Sroka,Ahmad Assalia,Nahum Beglaibter,Ram Elazary,Shai Meron Eldar,Orly Romano-Zelekha,David Goitein,David Goitein +10 more
TL;DR: In this paper, a retrospective review of hospital records of patients who underwent conversion from Laparoscopic sleeve gastrectomy (LSG) to Roux-n-Y gastric bypass (RYGB) or OAGB was performed in 7 bariatric centers between 2013 and 2019.
46
Lithium Toxicity with Severe Bradycardia Post Sleeve Gastrectomy: a Case Report and Review of the Literature
TL;DR: A 61-year-old male patient presented with lithium toxicity, including newly diagnosed severe bradycardia requiring a permanent pacemaker, after undergoing sleeve gastrectomy, and potential solutions are provided for clinicians treating bariatric patients with lithium.
33
Oral levothyroxine therapy postbariatric surgery: Biopharmaceutical aspects and clinical effects.
TL;DR: A mechanistic overview of levothyroxine absorption is provided and close monitoring of both the clinical presentation and plasma thyroid-stimulating hormone and T4 levels is strongly advised for patients after bariatric surgery.
33
Increased Paracetamol Bioavailability After Sleeve Gastrectomy: A Crossover Pre- Vs. Post-Operative Clinical Trial
Daniel Porat,Milica Markovic,Moran Zur,Noa Fine-Shamir,Carmil Azran,Gad Shaked,David Czeiger,Julie Vaynshtein,Ilya Replyanski,Gilbert Sebbag,Arik Dahan +10 more
TL;DR: Overall, decreased paracetamol exposure in obesity, with recovery to normal drug levels (caplet) or even higher (syrup) post-LSG, was revealed, and attention to par acetamol effectiveness/safety in Obesity, and after bariatric surgery, is prudent.
29
Impaired oral absorption of methylphenidate after Roux-en-Y gastric bypass.
TL;DR: A case of 52-year-old male patient with morbid obesity and attention-deficit/hyperactivity disorder who experienced lack of methylphenidate efficacy after Roux en-Y gastric bypass (RYGB), which was eventually resolved by using the transdermal patch instead of an oral product.
22